The Briefing

Continuous newsroom coverage of clinically relevant evidence — newest first.

Earlier

24 stories
  1. Tranexamic Acid Efficacy Varies by Breast Procedure Type
    Plastic & Reconstructive Surgery ·Cohort Study · May 20, 2026

    Tranexamic Acid Efficacy Varies by Breast Procedure Type

    A retrospective cohort study clarifies which breast surgeries benefit from tranexamic acid for hematoma prevention.

  2. Chronic Pain Mechanisms Show Distinct Cortical Connectivity Patterns
    Pain ·Cohort Study · May 20, 2026

    Chronic Pain Mechanisms Show Distinct Cortical Connectivity Patterns

    A study using TMS-EEG identifies neurophysiological differences across nociceptive, neuropathic, and nociplastic pain phenotypes.

  3. THA Approaches Yield Similar Patient Outcomes, Distinct Gait Biomechanics
    Annals of Physical and Rehabilitation Medicine ·Cohort Study · May 20, 2026

    THA Approaches Yield Similar Patient Outcomes, Distinct Gait Biomechanics

    While patient-reported improvements are consistent across THA approaches, minimally invasive techniques offer specific early gait efficiency.

  4. Amitriptyline Not Superior to Placebo for Leprosy-Related Neuropathic Pain
    Pain ·Randomized Controlled Trial · May 20, 2026

    Amitriptyline Not Superior to Placebo for Leprosy-Related Neuropathic Pain

    A randomized controlled trial found amitriptyline did not offer additional analgesia as add-on therapy for neuropathic pain in leprosy.

  5. TMEM106B Variant Delays FTD Onset in GRN Mutation Carriers
    Molecular Psychiatry ·Cohort Study · May 20, 2026

    TMEM106B Variant Delays FTD Onset in GRN Mutation Carriers

    A specific genetic variant significantly reduces FTD onset risk and extends median onset age by 14 years in GRN mutation carriers.

  6. Muscle Cramp Impact Index Validated for Multidimensional Symptom Assessment
    Neurology ·Diagnostic Accuracy Study · May 20, 2026

    Muscle Cramp Impact Index Validated for Multidimensional Symptom Assessment

    A new 14-item tool measures how muscle cramps interfere with sleep and daily life across neuromuscular, renal, and hepatic conditions.

  7. Male Facelift Hematoma Rates Similar to Females With Standardized Protocols
    Plastic & Reconstructive Surgery ·Cohort Study · May 20, 2026

    Male Facelift Hematoma Rates Similar to Females With Standardized Protocols

    A matched cohort analysis indicates that male facelift patients experience comparable hematoma rates to females when modern surgical protocols.

  8. Dupilumab Reduces COPD Hospitalizations, ED Visits, and Corticosteroid Use
    American Journal of Respiratory and Critical Care Medicine ·Meta-Analysis · May 20, 2026

    Dupilumab Reduces COPD Hospitalizations, ED Visits, and Corticosteroid Use

    A pooled analysis of two phase 3 trials shows dupilumab significantly lowers healthcare utilization and corticosteroid burden in COPD patients.

  9. Selective Early PDA Pharmacotherapy Feasible in Extremely Preterm Infants
    Archives of Disease in Childhood Fetal & Neonatal ·Randomized Controlled Trial · May 20, 2026

    Selective Early PDA Pharmacotherapy Feasible in Extremely Preterm Infants

    A pilot randomized trial demonstrates the feasibility of a targeted medical approach for patent ductus arteriosus in infants under 26 weeks'.

  10. Non-Ischemic Dilated Cardiomyopathy: Higher Prevalence, Complex Genetics
    Nature Reviews Cardiology ·Narrative Review · May 20, 2026

    Non-Ischemic Dilated Cardiomyopathy: Higher Prevalence, Complex Genetics

    Updated estimates suggest non-ischemic dilated cardiomyopathy affects 1 in 220, driven by diverse genetic and environmental factors.

  11. New Tool Assesses Integrative Oncology Competencies in Trainees
    Journal of Pain and Symptom Management ·Randomized Controlled Trial · May 20, 2026

    New Tool Assesses Integrative Oncology Competencies in Trainees

    A validated questionnaire helps evaluate baseline clinical skills in integrative oncology among healthcare provider trainees, supporting targeted.

  12. Remote Multicomponent Rehabilitation Does Not Improve Quality of Life for ICU Survivors
    JAMA ·Randomized Controlled Trial · May 20, 2026

    Remote Multicomponent Rehabilitation Does Not Improve Quality of Life for ICU Survivors

    A randomized trial found a 6-week remote rehabilitation program did not significantly enhance health-related quality of life at 8 weeks.

  13. Acquired Anosmia Affects Quality of Life More Than Congenital Anosmia
    Rhinology ·Cohort Study · May 20, 2026

    Acquired Anosmia Affects Quality of Life More Than Congenital Anosmia

    A study of 59 patients reveals how the origin and duration of anosmia influence perceived impairment and coping.

  14. ICU Readmission Increases 60-Day Mortality Regardless of Frailty Status
    Critical Care Medicine ·Cohort Study · May 20, 2026

    ICU Readmission Increases 60-Day Mortality Regardless of Frailty Status

    A large registry study finds frail, readmitted patients face the highest mortality, but frailty does not alter readmission's incremental risk.

  15. Prehospital Whole Blood Does Not Reduce 30-Day Mortality Over Components
    New England Journal of Medicine ·Randomized Controlled Trial · May 20, 2026

    Prehospital Whole Blood Does Not Reduce 30-Day Mortality Over Components

    A large-scale trial found no significant difference in 30-day mortality between prehospital whole blood and component transfusions for trauma.

  16. Spatial Proteomics Identifies Plaque-Associated Microglia in Alzheimer's Brains
    Nature Neuroscience ·Cross-Sectional Study · May 20, 2026

    Spatial Proteomics Identifies Plaque-Associated Microglia in Alzheimer's Brains

    A new imaging technology reveals a specific microglial subpopulation linked to dense amyloid-beta plaques in human Alzheimer's disease.

  17. AD109 Reduces Apnea-Hypopnea Index in PAP-Intolerant OSA Patients
    American Journal of Respiratory and Critical Care Medicine ·Randomized Controlled Trial · May 20, 2026

    AD109 Reduces Apnea-Hypopnea Index in PAP-Intolerant OSA Patients

    An oral combination of aroxybutynin and atomoxetine significantly improved objective respiratory metrics over 26 weeks.

  18. Stag2 Deficiency Reprograms GATA1 Binding, Driving Dyserythropoiesis in Myelodysplastic Syndromes
    Blood Journal ·Animal Study · May 20, 2026

    Stag2 Deficiency Reprograms GATA1 Binding, Driving Dyserythropoiesis in Myelodysplastic Syndromes

    Loss of Stag2 alters chromatin accessibility, redirecting GATA1's transcriptional activity from erythroid to megakaryocyte pathways.

  19. Genetic Maps Reveal Psychiatric Disorder Clusters, Clinical Feature Links
    World Psychiatry ·Cohort Study · May 20, 2026

    Genetic Maps Reveal Psychiatric Disorder Clusters, Clinical Feature Links

    A Swedish register study maps genetic risk for 12 disorders, showing how liabilities vary with sex, onset age, and recurrence.

  20. MSC-Exos Restore Hippocampal Neuron Morphology After Stress via Wnt5a Pathway
    Brain Research ·In Vitro Study · May 20, 2026

    MSC-Exos Restore Hippocampal Neuron Morphology After Stress via Wnt5a Pathway

    Mesenchymal stem cell-derived exosomes mitigate stress-induced morphological deficits in hippocampal neurons through a specific signaling pathway.

  21. PU.1 Activation Identifies Low-Risk MDS Patients at High Progression Risk
    Blood ·Cohort Study · May 20, 2026

    PU.1 Activation Identifies Low-Risk MDS Patients at High Progression Risk

    A molecular signature involving PU.1 genomic occupancy distinguishes a subset of low-risk MDS patients prone to progression and reduced survival.

  22. Periventricular Lesions Drive Cognitive Decline by Disrupting Cholinergic Pathways in Parkinson's
    Brain ·Cohort Study · May 20, 2026

    Periventricular Lesions Drive Cognitive Decline by Disrupting Cholinergic Pathways in Parkinson's

    White matter injury triggers cortical terminal loss and retrograde atrophy, identifying a structural biomarker for cognitive risk.

  23. PET Imaging Tracks Metabolic Decline Across ALS Clinical Stages
    Brain ·Cohort Study · May 20, 2026

    PET Imaging Tracks Metabolic Decline Across ALS Clinical Stages

    A large cohort study links King's staging to progressive loss of brain connectivity and transient cerebellar recruitment in ALS.

  24. Tezepelumab Reduces Exacerbations, Improves Lung Function in Diverse Severe Asthma Cohort
    American Journal of Respiratory and Critical Care Medicine ·Cohort Study · May 19, 2026

    Tezepelumab Reduces Exacerbations, Improves Lung Function in Diverse Severe Asthma Cohort

    A real-world phase 4 study shows tezepelumab's effectiveness and safety across various severe asthma phenotypes and underrepresented patient groups.